Mitchell H. Finer, Chief Scientific Officer at bluebird bio, Inc. (BLUE), sold 30,000 shares at $91.16 ($2.7M) on 2015-01-02, disclosed to the SEC on 2015-01-06.
Scheduled sale ($2.7M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.24 | 9,355 | $825K | 30.6% |
| 2 | $88.89 | 3,552 | $316K | 11.7% |
| 3 | $90.17 | 6,868 | $619K | 22.9% |
| 4 | $91.16 | 2,050 | $187K | 6.9% |
| 5 | $92.02 | 7,501 | $690K | 25.6% |
| 6 | $92.96 | 674 |
| $63K |
| 2.3% |
| Total | $90.01 avg | 30,000 | $2.7M | 100% |
| Filing → |
| BLUE | SELL | 2015-05-19 | $2.3M | — | Filing → |
| BLUE | SELL | 2015-05-06 | $2.0M | — | Filing → |
| BLUE | SELL | 2015-04-22 | $1.9M | — | Filing → |